Filtered By:
Management: Health Insurance
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 9040 results found since Jan 2013.
REIN: a tool at the service of health authorities
Nephrol Ther. 2023 Aug 28;18(S2):76-80. doi: 10.1016/S1769-7255(22)00573-9.ABSTRACTOn the occasion of the 20th anniversary of the REIN (French Renal Epidemiology and Information Network), a summary work on the contributions of the national French ESKD register was carried out. On the issue of its link with health authorities, the following key messages were retained. One of the purposes of REIN is to contribute to a better understanding about patient management and its evolution, and thus to be called upon to develop health strategies aimed at improving the prevention and treatment of chronic renal failure. Indeed, the pla...
Source: Nephrologie and Therapeutique - August 28, 2023 Category: Urology & Nephrology Authors: Philippe Tuppin Cl émence Béchade C écile Couchoud Source Type: research
Incidence of and Factors Associated With Recurrent Firearm Injury Among Patients Presenting to St. Louis Trauma Centers, 2010 to 2019 : A Cohort Study
CONCLUSION: Recurrent injury and death are frequent among survivors of firearm injury, particularly among patients from socially vulnerable areas. Our findings highlight the need for interventions to prevent recurrence.PRIMARY FUNDING SOURCE: Emergency Medicine Foundation-AFFIRM and Missouri Foundation for Health.PMID:37639717 | DOI:10.7326/M23-0069
Source: Annals of Internal Medicine - August 28, 2023 Category: Internal Medicine Authors: Kristen L Mueller Benjamin P Cooper Vicki Moran Daphne Lew Rachel Ancona Joshua M Landman Marguerite Spruce Phillip Marotta David B Liss Michael A Mancini Douglas Schuerer Megan E Ranney Randi E Foraker Source Type: research
One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients
CONCLUSIONS: The authors have demonstrated that the one-year persistence of RAAS inhibitor FDCs varies significantly in hypertensive patients. ACE inhibitor/CCB FDCs were found to be the most advantageous. Orv Hetil. 2023; 164(34): 1337-1341.PMID:37634155 | DOI:10.1556/650.2023.32840
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: G ábor Simonyi Tam ás Ferenci Ervin Finta Mih ály Medvegy Istv án Wittmann Source Type: research
